Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.
Protocol | N0577 |
---|---|
Cancer Type: | Codeleted Anaplastic Glioma |
Fast Facts |
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG BN003 |
---|---|
Cancer Type: | MENINGIOMA |
Fast Facts |
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | CCTG MA.39 Adjuvant |
---|---|
Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG CC003 |
---|---|
Cancer Type: | SCLC |
Fast Facts |
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG GU002 |
---|---|
Cancer Type: | Prostate |
Fast Facts |
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy with or Without Adjuvant Docetaxel
Protocol | NRG GU005 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Protocol | NRG GU009 |
---|---|
Cancer Type: | HIGH RISK PROSTATE CANCER |
Fast Facts |
PARALLEL PHASE III RANDOMIZED TRIALS FOR HIGH RISK PROSTATE CANCER EVALUATING DE-INTENSIFICATION FOR LOWER GENOMIC RISK AND INTENSIFICATION OF CONCURRENT THERAPY FOR HIGHER GENOMIC RISK WITH RADIATION (PREDICT-RT*)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1806 |
---|---|
Cancer Type: | Bladder Cancer |
Fast Facts |
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab In Localized Muscle Invasive Bladder Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG GY006 |
---|---|
Cancer Type: | GYN-newly diagnosed, bulky stage |
Fast Facts |
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA3132 |
---|---|
Cancer Type: | Head and Neck |
Fast Facts |
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Protocol | NRG HN005 |
---|---|
Cancer Type: | Oropharyngeal Cancer |
Fast Facts |
A Randomized Phase II/III Trial of De-intensified Radiation Therapy for Patients with Early-Stage, p16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG LU002 |
---|---|
Cancer Type: | METASTATIC NON-SMALL CELL LUNG CANCER |
Fast Facts |
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG CC003 |
---|---|
Cancer Type: | SCLC |
Fast Facts |
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.